Health Catalyst, Inc.

符号: HCAT

NASDAQ

6.67

USD

今天的市场价格

-3.2448
市盈率
0.0000
PEG比率
393.75M
MRK市值
0.00%
DIV收益率

Health Catalyst, Inc. (HCAT) 财务报表

Q: 什么是 Health Catalyst, Inc. (HCAT) 总资产是多少？

Health Catalyst, Inc. (HCAT) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Health Catalyst, Inc. (HCAT). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Health Catalyst, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018
balance-sheet.row.cash-and-short-term-investments	317.7	363.5	445	270.9	228.3	33.2	51.5
balance-sheet.row.short-term-investments	211.5	247.2	251.8	178.9	210.2	4.8	28.5
balance-sheet.row.net-receivables	61.2	48	48.8	48.3	27.6	27.7	17.1
balance-sheet.row.inventory	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	12.3	16.3	14.6	10.6	8.4	6	2.9
balance-sheet.row.total-current-assets	391.2	427.8	508.4	329.8	264.2	66.9	71.4
balance-sheet.row.property-plant-equipment-net	39.6	42.6	44.4	37.6	8.1	11	5.4
balance-sheet.row.goodwill	190.7	186	170	107.8	3.7	3.7	3.7
balance-sheet.row.intangible-assets	73.4	92.2	104.8	98.9	25.5	28.3	29.6
balance-sheet.row.goodwill-and-intangible-assets	264	278.2	274.8	206.7	29.2	32	33.3
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	6.9	3.7	4.5	3.6	0.8	1.1	0.2
balance-sheet.row.total-non-current-assets	310.6	324.5	323.7	247.9	38.1	44.1	38.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0
balance-sheet.row.total-assets	701.8	752.3	832.1	577.7	302.4	111	110.3
balance-sheet.row.account-payables	6.6	4.4	4.7	5.3	3.6	1.8	0.8
balance-sheet.row.short-term-debt	3.4	3.4	3.4	2.6	2.8	3.9	2.1
balance-sheet.row.tax-payables	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	228	244.5	201.2	192.7	49.9	23	10.5
Deferred Revenue Non Current	0.1	0.1	0.9	1.9	1.5	7.3	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	23.3	19.7	28.3	32.9	11.1	11.4	17.1
balance-sheet.row.total-non-current-liabilities	245.9	244.8	216.9	213.6	53.5	443.9	339
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	17.7	21.5	23.7	26.3	4.5	6.8	3
balance-sheet.row.total-liab	334.9	327.3	310	301.6	101.7	485.7	369.7
balance-sheet.row.preferred-stock	0	0	0	0	302.4	0	0
balance-sheet.row.common-stock	1484.1	1424.7	0.1	0	0	0	0
balance-sheet.row.retained-earnings	-1117.2	-999	-878.9	-725.6	-610.5	-374.8	-259.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	-0.6	-0.1	0.1	0.1	0	0
balance-sheet.row.other-total-stockholders-equity	0	0	1401	1001.6	508.7	0	5.5
balance-sheet.row.total-stockholders-equity	366.9	425	522.1	276.1	200.6	-374.8	-259.5
balance-sheet.row.total-liabilities-and-stockholders-equity	701.8	752.3	832.1	577.7	302.4	111	110.3
balance-sheet.row.minority-interest	0	0	0	0	0	0	0
balance-sheet.row.total-equity	366.9	425	522.1	276.1	200.6	-374.8	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-
Total Investments	211.5	247.2	251.8	178.9	210.2	4.8	28.5
balance-sheet.row.total-debt	249.1	248	204.6	195.3	52.7	26.9	12.6
balance-sheet.row.net-debt	142.8	131.7	11.4	103.3	34.6	-1.5	-10.4

现金流量表

在 Health Catalyst, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2022	2020	2018
cash-flows.row.net-income	-118.1	-137.4	-153.2	-115	-60.1	-62	-47
cash-flows.row.depreciation-and-amortization	45.2	48.3	37.5	18.7	9.2	7.4	5.9
cash-flows.row.deferred-income-tax	0	-4.5	-7.1	-1.3	0	-0.2	0
cash-flows.row.stock-based-compensation	55.8	72.1	65.1	38	17.8	4.2	4.2
cash-flows.row.change-in-working-capital	-13.7	-13.9	4.6	-3.8	-1.3	9.8	-0.2
cash-flows.row.account-receivables	-13.7	0.8	0.1	-16.4	0.1	-3.6	4.4
cash-flows.row.inventory	0	0	-8.3	-7.1	-3.7	2.5	-2.6
cash-flows.row.account-payables	4.9	-4.7	5.2	8.2	-0.1	4.4	-6.3
cash-flows.row.other-working-capital	-4.9	-10	7.6	11.5	2.3	6.5	4.2
cash-flows.row.other-non-cash-items	-2.2	0.2	29.9	37.3	2.1	0.5	0.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-14.3	-17.4	-18.5	-10.5	-4.3	-2.5	-3.3
cash-flows.row.acquisitions-net	-11.4	-27.8	-46.8	-101.7	1.9	0.2	0.9
cash-flows.row.purchases-of-investments	-290.8	-309	-261.4	-189.5	-256	-14	-46.4
cash-flows.row.sales-maturities-of-investments	336.8	315.2	186.9	219.1	50.7	37.9	72.1
cash-flows.row.other-investing-activites	0	0	0	0	-1.9	-0.2	-0.8
cash-flows.row.net-cash-used-for-investing-activites	20.3	-39	-139.7	-82.6	-209.6	21.4	22.4
cash-flows.row.debt-repayment	0	0	0	-57	-21.8	0	0
cash-flows.row.common-stock-issued	4.5	4	245.2	40.5	194.6	0	0
cash-flows.row.common-stock-repurchased	-1.8	-8.4	0	0	0	-8.7	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	4.5	1.8	18.9	199.1	58.6	33.1	24.9
cash-flows.row.net-cash-used-provided-by-financing-activities	2.7	-2.6	264.1	182.6	231.4	24.3	24.9
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-10	-76.9	101.3	73.9	-10.4	5.5	10.4
cash-flows.row.cash-at-end-of-period	106.3	116.3	193.2	92	18	28.4	23
cash-flows.row.cash-at-beginning-of-period	116.3	193.2	92	18	28.4	23	12.5
cash-flows.row.operating-cash-flow	-33.1	-35.3	-23.1	-26.1	-32.2	-40.3	-36.8
cash-flows.row.capital-expenditure	-14.3	-17.4	-18.5	-10.5	-4.3	-2.5	-3.3
cash-flows.row.free-cash-flow	-47.4	-52.7	-41.6	-36.6	-36.5	-42.8	-40.2

利润表行

Health Catalyst, Inc. 的收入与上期相比变化了 NaN%。据报告, HCAT 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018
income-statement-row.row.total-revenue	295.9	276.2	241.9	188.8	154.9	112.6	73.1
income-statement-row.row.cost-of-revenue	203.3	143	124.4	98.1	75.3	59.9	43.6
income-statement-row.row.gross-profit	92.6	133.2	117.6	90.8	79.6	52.7	29.4
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0	48.3	37.5	18.7	9.2	0	0
income-statement-row.row.operating-expenses	178.4	273.2	261.2	186.9	134.5	112.8	75
income-statement-row.row.cost-and-expenses	381.7	416.2	385.6	285	209.8	172.7	118.6
income-statement-row.row.interest-income	16.4	5.7	0.8	2.1	2.8	0.6	0.5
income-statement-row.row.interest-expense	7.3	1.7	16.5	11.6	3.4	2.6	1.5
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-32	-1.7	-16.5	-20.1	-5.1	0	0
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0	48.3	37.5	18.7	9.2	0	0
income-statement-row.row.total-operating-expenses	-32	-1.7	-16.5	-20.1	-5.1	0	0
income-statement-row.row.interest-expense	7.3	1.7	16.5	11.6	3.4	2.6	1.5
income-statement-row.row.depreciation-and-amortization	45.2	48.3	37.5	18.7	9.2	7.4	5.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-85.8	-140	-143.7	-96.1	-54.9	-60.1	-45.5
income-statement-row.row.income-before-tax	-117.8	-141.7	-160.1	-116.2	-60	-62.1	-47
income-statement-row.row.income-tax-expense	0.4	-4.3	-6.9	-1.2	0.1	-0.1	0
income-statement-row.row.net-income	-118.1	-137.4	-153.2	-115	-60.1	-62	-47